Sort by
Refine Your Search
-
immunosuppression, akin to PDL1-PD1 interactions. In collaboration with Carolyn Bertozzi’s group, we are developing bifunctional proteins that include an antibody to cell surface cancer proteins (e.g. PSMA, CA9) and
-
for (1) engineering BPAN genetic variants into cell lines; (2) developing cellular assays including of autophagy function and cellular survival; (3) working with the Stanford high throughput drug screening
-
to outstanding new PhD recipients who have a demonstrated ability to generate high-quality, policy-relevant research on critical issues related to global development. We invite applications for multidisciplinary
-
for Spatial Biology Description: The Lu Lab at Stanford University is seeking a postdoctoral fellow with deep expertise in advanced AI and generative modeling to develop computational frameworks that transform
-
. The Translation Research Group is recruiting a highly motivated postdoctoral research scholar in Radiation Oncology Department at Stanford University School of Medicine. Major focus of the Group is to develop AI
-
(Siglecs) on immune cells to effect immunosuppression, akin to PDL1-PD1 interactions. In collaboration with Carolyn Bertozzi’s group, we are developing bifunctional proteins that include an antibody to cell
-
the Divisions of Immunology and Rheumatology and Pain Medicine. The fellow will have access to a collaborative environment and institutional resources supporting career development in academic medicine, including
-
translate extracellular cues sensed by GPCRs into specific phenotypic outputs. Developing quantitative proteomics approaches to capture the spatiotemporal organization of signaling networks and combining
-
will use a combination of scRNAseq, spatial transcriptomics, and highly-multiplexed imaging to understand how human macrophages respond to the early stages of cancer development. They will be a part of
-
available immediately in the Molecular Imaging Program at Stanford (MIPS). The successful candidates will join a dynamic research group focusing on the development of peptide-based therapeutics and